Magnesium-dependent regulation of myocardial membrane excitability

Magnesium-dependent regulation of myocardial membrane excitability is a critical physiological process where magnesium ions (Mg2+) modulate the electrical activity of cardiac myocytes. Magnesium serves as a 'natural calcium antagonist' by inhibiting L-type calcium channels (CACNA1C) and competing with calcium for intracellular binding sites, thereby preventing calcium-induced triggered activity and stabilizing the myocardium (StatPearls, 2023; PubMed, 29093983). It is also an essential regulator of the inward rectifier potassium channel (KCNJ2/Kir2.1), where intracellular magnesium provides the physical pore block necessary for inward rectification and the maintenance of a stable resting membrane potential (UniProt, P60584). Furthermore, magnesium is a required cofactor for the Na+/K+-ATPase pump, which preserves the ionic gradients necessary for excitability (NIH, 2022). Clinically, the loss of this regulation due to hypomagnesemia is a major risk factor for life-threatening arrhythmias, such as Torsades de Pointes and ventricular fibrillation (PubMed, 30191631). Therapeutic administration of magnesium salts, such as magnesium sulfate, is a standard intervention to stabilize membrane potential and terminate specific tachyarrhythmias (StatPearls, 2023).

Other names

Magnesium-mediated cardiac electrophysiologyMyocardial magnesium homeostasisMagnesium-dependent stabilization of cardiac membranesCardiac magnesium regulation

Magnesium acts as a physiological non-competitive antagonist of L-type calcium channels and provides a voltage-dependent block of inward rectifier potassium channels (Kir2.1), which is essential for maintaining the resting membrane potential and modulating action potential duration. It also serves as a mandatory cofactor for the Na+/K+-ATPase pump, ensuring the maintenance of essential ionic gradients across the myocardial cell membrane.